Background: Mesenchymal stem cells (MSC) are multipotent and reside in bone marrow (BM), adipose tissue and many other tissues. However, the molecular foundations underlying the differences in proliferation, differentiation potential and paracrine effects between adipose tissue-derived MSC (ASC) and BM-derived MSC (BM-MSC) are not well-known. Therefore, we investigated differences in the gene and secretory protein expressions of the 2 types of MSC.
esenchymal stem cells (MSC) are multipotent cells that reside within various tissues, including bone marrow (BM), adipose tissue and many other tissues, 1,2 and can differentiate into a variety of cell types of mesodermal lineage. 1, 3 MSC can be expanded in vitro over the short term, and they are thought to be an attractive tool for cell therapy. It has been demonstrated in animal and human studies of cardiovascular disease that transplanted BM-MSC induce neovascularization and differentiate into functional cells. [4] [5] [6] [7] [8] In addition, recent studies suggest that MSC exert tissue regeneration, secreting various kinds of angiogenic and cytoprotective factors. 6,9, 10 
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Subcutaneous adipose tissue can be harvested more safely and noninvasively than BM, and ASC have emerged as a possible alternative cell source to BM-MSC. 9, 11 We and others have demonstrated that ASC transplantation induces neovascularization in animal models of myocardial infarction and hindlimb ischemia. 12, 13 ASC are similar to BM-MSC in terms of morphology and surface marker expression. 14 However, few data exist regarding their differences in biological activity, such as proliferative activity, differentiation potential and productive ability. Using microarray and enzyme-linked immunosorbent
Microarray Analysis of ASC and BM-MSC
To compare the gene expression of ASC and BM-MSC, microarray analysis was performed according to previously reported methods. 17 Total RNA was extracted from cells using an RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. RNA was quantified by spectrometry, and its quality was confirmed by gel electrophoresis. Double-stranded cDNA was synthesized from 10 μg of total RNA, and in-vitro transcription was performed to produce biotin-labeled cRNA using GeneChip One-Cycle Target Labeling and Control Reagents (Affymetrix, Santa Clara, CA, USA) according to the manufacturer's instructions. After fragmentation, 10 μg of cRNA was hybridized with a GeneChip Rat Genome 230 2.0 Array (Affymetrix) containing 31,099 genes. The GeneChips were then scanned in a GeneChip Scanner 3000 (Affymetrix). Normalization, filtering and Gene Ontology analysis of the data were performed with GeneSpring GX 7.3.1 software (Agilent Technologies, Palo Alto, CA, USA). The raw data from each array were normalized as follows: each CEL file was preprocessed with RMA, and each measurement for each gene was divided by the 80 th percentile of all measurements.
Genes showing at least a 3-fold change were then selected.
Quantitative Real-Time Reverse-Transcription-Polymerase Chain Reaction (qRT-PCR) Total RNA was extracted from cultured BM-MSC and ASC as described, and 5 μg of total RNA was reverse-transcribed into cDNA using a QuantiTect reverse-transcription kit (Qiagen) according to the manufacturer's instructions. PCR amplification was performed in 50 μl containing 1 μl of cDNA and 25 μl of Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, amplified from the same samples, served as an internal control. After an initial denaturation at 95°C for 10 min, a 2-step cycle procedure was used (denaturation at 95°C for 15s, annealing and extension at 60°C for 1 min) for 40 cycles in a 7700 sequence detector (Applied Biosystems). Gene expression levels were normalized according to that of GAPDH.
ELISA
To investigate differences in protein secretion between ASC and BM-MSC, we measured the levels of various bioactive proteins, including proliferative and anti-apoptotic factors such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF) and adrenomedullin (AM); chemokines such as stem cell-derived factor-1α (SDF-1α); inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6); and adipokines such as leptin and plasminogen activator inhibitor-1 (PAI-1). Protein levels were measured in conditioned medium 24 h after medium replacement. MSC (1×10 6 cells/dish) were plated in 10-cm dishes and cultured in complete culture medium. After 24 h, conditioned medium (n=6) was collected and centrifuged at 2,000 g for 10 min, and the supernatant was filtered through a 0.22-μm filtration unit (Millipore, Bedford, MA, USA). Angiogenic and growth factors were measured by ELISA according to each of the manufacturer's instructions (VEGF, TNF-α: R&D Systems, Minneapolis, MN, USA; HGF: Institute of Immunology, Tokyo, Japan; AM: Phoenix Pharmaceuticals, Burlingame, CA, USA; IL-6: Pierce, Rockford, IL, USA; adiponectin: AdipoGen, Seoul, Korea; PAI-1, Oxford Biomedica Reseach, Oxford, CT, USA).
Statistical Analysis
Data are expressed as mean ± standard error of the mean. Comparisons of parameters among groups were made by 1-way ANOVA, followed by Newman-Keuls' test. Differences were NAKANISHI C et al. 
Results

Proliferation and Differentiation of ASC and BM-MSC
Both ASC and BM-MSC could be expanded on a plastic dish, and they exhibited a similar fibroblast-like morphology ( Figures 1A,B) . To examine the potential of ASC and BM-MSC to differentiate into adipocytes, the cells were cultured in adipogenesis medium for 21 days (Figures 1C,D) . Although lipid droplets were not observed in undifferentiated ASC or BM-MSC, ASC and BM-MSC cultured in adipogenesis 1E,F) . ASC proliferated more rapidly than BM-MSC; the number of ASC was approximately 10-fold higher than that of BM-MSC at the 40 th day (Figure 2) . In approximately 2 weeks, ASC had expanded almost 200-fold, whereas BM-MSC had expanded nearly 30-fold.
Differences in the Gene Expression of ASC and BM-MSC
Of 31,099 genes analyzed, 571 (1.8%) were more highly (>3-fold) expressed in ASC, whereas 571 genes (1.8%) were more highly (>3-fold) expressed in BM-MSC (Figure 3) . The genes showing the most enriched expression (>10-fold) in ASC and BM-MSC are listed in Table 1 . Of note, the genes that were highly expressed in ASC included various types of molecules involved in inflammation, such as IL-1α and IL-6, and chemotaxis, such as chemokine (C-C motif) ligand 20 and chemokine (C-X-C motif) ligand 5 ( Table 1) . The genes that were highly expressed in BM-MSC included differentiation-associated genes, such as WNT1-inducible signaling pathway protein 2 (Wisp2), osteomodulin and jagged1 ( Table 2) . Furthermore, the differential expression patterns of 5 representative genes in ASC and BM-MSC obtained by microarray were confirmed by qRT-PCR, which gave the relative expression of IL-1α as 438.2±560.9 (ratio ASC/BM-MSC, n=5), IL-6 as 54.0±26.6, MMP9 as 3.9±2.2, VEGF 1.8±0.4, and Wisp2 as 7.0±2.2.
To evaluate the genes upregulated in ASC, 571 genes that were more highly expressed in ASC were classified by functional annotation using gene ontology terms ( Table 3 ). The 31 terms listed had a P-value <0.00001, and included mitosis (eg, pituitary tumor-transforming 1, cyclin B1, cyclin-dependent kinase 2), immune response (eg, chemokine (C-C motif) ligand 20, cathepsin C and IL-1α) and response to stress (glutathione peroxidase 2, superoxide dismutase 2 and metallothionein). In BM-MSC, 22 terms were listed for the 571 enriched genes, and included regulation of organ development (eg, Wisp2, osteomodulin and bone morphogenetic protein 4), morphogenesis (cadherin 13, elastin and Neuropillin 2) and cell migration (chemokine (C-X3-C motif) ligand 1 and chemokine (C-X-C motif) receptor 4) ( Table 4) .
Differences Between ASC and BM-MSC in Secretory
Proteins Determined by ELISA In previous reports, MSC evoked a cell protective effect and induced angiogenesis via secretion of various cytokines, includ- To compare the proteins secreted by cultured ASC and BM-MSC, we used ELISA to investigate the production of several angiogenic and growth factors from ASC and BM-MSC cultures (Figure 4) . As compared with BM-MSC, ASC secreted significantly larger amounts of not only HGF and VEGF, which are growth and angiogenic factors, but also PAI-1 and IL-6, which are adipokines. On the other hand, BM-MSC secreted significantly larger amounts of SDF-1α, which is a cell migration-related chemokine, than ASC. There was no significant difference between ASC and BM-MSC for several secreted adipokines, such as adiponectin and TNF-α.
Discussion
In this study, we examined the differences between ASC and BM-MSC in proliferation, differentiation, gene expression and secreted proteins. We showed that (1) ASC are more proliferative than BM-MSC, although there is no difference in differentiation into adipocytes or osteocytes; (2) genes associated with mitosis, inflammation and stress response are highly expressed in ASC; (3) genes associated with regulation of organ development, morphogenesis and cell migration are highly expressed in BM-MSC; and (4) ASC secrete significantly larger amounts of growth factors and inflammatory cytokines than BM-MSC, although BM-MSC secrete significantly larger amounts of chemokine than ASC. In terms of differentiation, both ASC and BM-MSC differentiated into adipocytes and osteocytes, and there was no difference between them in adipogenesis in our quantitative analysis. A previous report demonstrated that BM-MSC had distinct osteogenic differentiation capability in comparison with ASC, 18 although we did not evaluate difference in osteogenesis between ASC and BM-MSC. Indeed, osteomodulin, which is an osteogenesis-related gene, was upregulated in BM-MSC in comparison with ASC ( Table 2) . Therefore, BM-MSC might have more osteogenic potential than ASC. These findings suggest that ASC and BM-MSC have multilineage potential and an equivalent potential to differentiate into unfavorable cells. Under these conditions, we found that ASC proliferated more rapidly than BM-MSC, and expanded 4-fold as much BM-MSC in approximately 2 weeks. Lee et al compared the proliferation and gene expression profile of human ASC and BM-MSC, 19 and also demonstrated that ASC differ from BM-MSC in terms of proliferation according to culture medium. A large number of MSC are needed for cell transplantation, so rapid proliferation of ASC ex vivo is thought to be a favorable source of transplanted cells in the acute clinical setting, although there remain prob- ASC, adipose tissue-derived mesenchymal stem cells. NAKANISHI C et al.
lems concerning tumorigenesis and instability. In this study, we carried out a comprehensive analysis in rat ASC and BM-MSC using microarrays. Interestingly, there was a considerable difference between the gene profile of our data and that of Lee et al, 19 who demonstrated that highly expressed genes in ASC accounted for less than 1% of all genes, and keratin 18, thrombospondin 1 and heat shock protein were included in the list of genes upregulated in ASC as compared with BM-MSC. Their human study was of 16-84-year-old patients undergoing arthroplasty and abdominoplasty, whereas we used 6-week-old rats. It is possible that differences in species and culture conditions, as well as age, contributed to these differences in gene expression.
We demonstrated that many of the genes that were highly expressed in ASC could be classified into categories such as mitosis, cell cycle and inflammatory cytokines, suggesting that ASC are more proliferative than BM-MSC. Thus, ASC transplant may not be superior to BM-MSC in terms of improvement of cardiac function in acute myocardial infarction, although it might be expected that ASC would contribute more to cell proliferation because of their secretion of VEGF and HGF. Also, ASC might initiate a stronger inflammatory response, because of the significantly increased upregulation of genes associated with inflammation as compared with BM-MSC. On the other hand, many of the genes that were highly expressed in BM-MSC were classified into categories such as organ development and morphogenesis. BM-MSC upregulated the expression of genes associated with cardiogenesis and angiogenesis, such as Wisp2, jagged1 and insulin-like growth factor binding protein 4 (IGFBP4). In particular, jagged1 and IGFBP4 have been reported to induce cardiogenesis and angiogenesis, respectively, via activation of notch signals and inhibition of Wnt signals. 20, 21 Indeed, a previous report demonstrated that BM-MSC transplantation into the infarcted heart induces cardiogenesis and angiogenesis. 22-24 On the other hand, ASC are also reported to be able to differentiate into cardiomyocytes. 25 Therefore, ASC and BM-MSC both might improve cardiac function by supplementing cardiomyocytes, as well as in a paracrine manner, although we did not investigate differences in differentiation into cardiomyocytes between them.
BM-derived mononuclear cells and MSC have been used for therapeutic angiogenesis in ischemic disease. 26,27 MSC are thought to be more effective than mononuclear cells as a source of transplanted cells because MSC secrete larger amounts of growth factors. 26 Recent studies suggest that MSC exert tissue regeneration not only by differentiation into specific cell types, but also through paracrine actions, secreting various kinds of angiogenic and cytoprotective factors, 5,10 as shown in the present study. A recent report has shown that the combination of VEGF and MSC can enhance angiogenesis after acute myocardial infarction in rats. 28 Additionally, a previous study demonstrated that BM-MSC activate cardiac progenitor cells, which have the ability to differentiate into cardiomyocytes, in a paracrine manner in vitro and in vivo. 29, 30 HGF and SDF-1α improve cardiac function via the activation of cardiac progenitor cells. 31 In our study, both ASC and BM-MSC secreted various cytokines and chemokines that are related to angiogenesis and cardiogenesis.
Although ASC are used as an adequate transplanted cell type for the treatment of ischemic limb disease, 32 ASC secrete larger amounts of not only inflammatory cytokines, such as IL-6, but also PAI-1 which promotes coagulation. In our gene analysis, several genes associated with other inflammatory cytokines and chemokines were upregulated in ASC. Not only the gene analysis but also the ELISA results suggested that ASC evoke more inflammation and thrombogenesis than BM-MSC. Therefore, ASC transplantation might be a more useful BM-MSC, bone marrow-derived mesenchymal stem cells. Adipose Tissue-and Bone Marrow-Derived MSC treatment for chronic ischemia without severe inflammation. In this study, we investigated ASC and BM-MSC obtained from young, 6-week-old rats, and we did not examine differences among various generations of rats. A previous report showed that MSC are subject to molecular genetic changes, such as alterations in p53, HGF and VEGF, during aging. 33 Our results might reflect the character of MSC obtained from young rats, contributing to difference from results in humans. 18 We need to further investigate differences between ASC and BM-MSC not only derived from rats but also derived from humans of various ages.
Conclusion
We have demonstrated difference in proliferation and gene expression between ASC and B-MSC, and accordingly, we suggest the importance of selecting the appropriate cell type for transplantation according to the therapeutic indication.
